Urinary Smad1 as a New Biomarker for Diabetic Nephropathy in Patients With Type 1 Diabetes Mellitus

Journal of Diabetes & Metabolism
doi 10.4172/2155-6156.1000756
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Association of Diabetic Nephropathy With Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

International Journal of Advances in Medicine
2019English

Assessment of Progranulin in Egyptian Type 2 Diabetic Patients as a Novel Biomarker for Diabetic Nephropathy

International Journal of Biosciences (IJB)
2016English

The Search for Molecular Prognostic Markers of Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus

International Journal of Biomedicine
2016English

Prevalence of Diabetic Retinopathy in Patients With Type 1 Diabetes Mellitus

Revista da Associacao Medica Brasileira
Medicine
2009English

Investigation of DNA Polymorphisms in SMAD Genes for Genetic Predisposition to Diabetic Nephropathy in Patients With Type 1 Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Diabetic Nephropathy Among Type 2 Diabetes Mellitus Patients in Dr. Cipto Mangunkusumo Hospital

Medical Journal of Indonesia
Medicine
2004English

Diabetic Nephropathy an Obvious Complication in Long Term Type 1 Diabetes Mellitus: A Case Study

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Association of TGF-β1 Polymorphism With Type 2 Diabetes Mellitus and Diabetic Nephropathy in Saudi Patients

International Journal of Advanced Research
2016English

HbA1c as Screening Biomarker of Dyslipidemia in Type 2 Diabetes Mellitus Patients

International Journal of Advances in Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy